Worldwide Clinical Trials was founded in 1986 by Dr. Neal R. Cutler and his team with a commitment to advancing medical science. Initially starting as an investigational site, the company expanded into a global Contract Research Organization (CRO) by 1995, known for its focus on site and patient-centered clinical trials and research. Its philosophy emphasizes methodological rigor, quality, safety, and speed in drug development projects.
With over 30 years of experience, Worldwide Clinical Trials delivers full-service clinical expertise covering preclinical, Phase I-IV clinical development, post-approval studies, and real-world evidence. The company specializes in therapeutic areas including Cardiovascular, Metabolic, Neuroscience, Oncology, and Rare Diseases. It operates across 60 countries with offices in North and South America, Europe, Russia, and Asia, supported by more than 2,600 employees worldwide.
The company is recognized for innovative techniques in interventional clinical research and high senior management oversight to ensure project follow-through. These qualities have established Worldwide Clinical Trials as a reliable partner to biotechnology and pharmaceutical industries for successful clinical trial execution. They position themselves as a leading global CRO delivering comprehensive services with a personalized approach that benefits study outcomes.
Their headquarters are located in Morrisville, North Carolina, USA, embodying their roots in the Research Triangle Park area, a major hub for biotechnology and pharmaceuticals. Worldwide Clinical Trials continues to grow as a mid-sized CRO that balances global reach with expert, quality-driven service to accelerate the development of new therapies worldwide.